AUCurrent Trials
  • Home
  • Clinical Trials
  • Tinnitus Studies Pukekohe

Tansy Tinnitus Study Pukekohe

Pukekohe Auckland

Momentum Clinical Research is inviting adults aged 18 to 64 who have had tinnitus for at least 6 months to register interest in a clinical research study. Researchers are studying an investigational oral medication to learn more about its safety, tolerability, and effects on tinnitus-related symptoms.

Description

What to expect

Study details

Ages

18-64

Duration

Participants with tinnitus may be in the study for up to about 7 weeks. This includes screening up to 21 days before dosing, at-home study medication once each evening for 14 days, clinic visits on Day 1, around Day 8 and Day 15, and a safety follow-up visit around Day 21.

Compensation

Participants will be compensated up to $6,750

Eligibility Criteria

You may qualify for this study if you:

•   Are aged 18 to 64
•   Have had tinnitus for at least 6 months
•   Are otherwise generally healthy
•   Can attend study visits for Screening and also on Day 1, Day 8, Day 15, and Day 21
•   Are willing to take study capsules at home after an evening meal
•   Are willing to follow safety instructions after taking the study medication

Other criteria may apply.

Locations

Pukekohe Auckland

Description

This study is for adults with tinnitus. Tinnitus can involve hearing ringing, buzzing, hissing or similar sounds when there is no external source. Researchers are studying a potential medication intended for adults with chronic tinnitus.

The information collected will help researchers learn more about the safety and tolerability of the study medication and its effects on tinnitus-related aspects of daily living, tinnitus loudness and annoyance, sleep, and well-being.

What to expect

Participants will take the study medication at home once daily in the evening after an evening meal for 14 days.
You will attend clinic visits for health assessments, including physical checks, blood and urine tests, heart tracing, and tinnitus questionnaires. Your safety and wellbeing will be monitored by our experienced clinical team throughout the study.
You will also be asked to follow safety instructions after taking the study medication. 

Why join a clinical research study?

•    Contribute to the development of potential medication options
•    Help support future tinnitus research
•    Receive health checks from our professional medical team

Your privacy is important. All personal information will be kept strictly confidential.

Apply Now

Fill out your details and our team will be in touch with you regarding this study.

Momentum Clinical Research NZ is a member of the Global Site Holdings Group. Global Site Holdings Pty Limited ACN 668 977 062 trading as Momentum Clinical Research ABN 51 668 977 062 and our related entities (we, us, our), will use the Personal Information you have provided in the above form to review and respond to your enquiry, to contact you about any future trials or studies you may be eligible for, and otherwise in accordance with our Privacy Policy and as required and authorised by law. We may not be able to provide you with a complete response or a response at all to your enquiry if you do not provide the requested information. By clicking 'Submit' you agree to our Privacy Policy which contains further information about how we collect, use, store or disclose your Personal Information, how you may seek access and correction of your Personal Information, and how you may make a complaint about a breach of privacy. If you have questions, please contact us at contact@momentumclinicalresearch.com.

Therapeutic AreasClinical TrialsAboutContactCareersNews
ParticipantsSponsors

New Zealand locations

AucklandPukekohe AucklandNorth AucklandWest AucklandWaikatoRotoruaPalmerston NorthHutt ValleyKapitiWellingtonNelsonChristchurchDunedin

Australian locations

Taringa BrisbaneSunshine MelbourneDarlinghurst SydneySt Leonards Sydney

2026 © Momentum Clinical Research

Privacy Policy